Screening for colorectal cancer

Scandinavian Journal of Surgery

Volumn 92, Issue 1, 2003, Pages 20-24

  Kronborg, Ole ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Adenomas; Colorectal cancer; Polyps; Screening

Indexed keywords

ADENOMA; BARIUM ENEMA; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; ENTERITIS; HIGH RISK POPULATION; HUMAN; REVIEW; SIGMOIDOSCOPY;

EID: 0037250465     PISSN: 14574969     EISSN: None     Source Type: Journal    
DOI: 10.1177/145749690309200104     Document Type: Review

References (41)

1. Vasen HFA, Bülow S and The Leeds Castle Polyposis Group: Guidelines for thesurveillance and management of familial adenomatous polyposis (FAP): a world wide survey among 41 registries. Colorectal Dis 1999;1:214-221
2. Bülow C, Vasen H, Järvinen H, Björk J, Bisgaard ML, Bülow S: Ileorectal anastomosis is appropriate for a subset of patients with familial adenomatous polyposis. Gastroenterol 2000;119:1454-1460
3. Vasen HFA, Ballegooijen M van, Buskens E, Kleibeuker JK, Taal BG, Griffioen G, Nagengast FM, Menko FH, Khan P Meera: A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers. Cancer 1998;82:1632-1637
4. Lindgren G, Liljegren A, Jaramillo E, Rubio C, Lindholm A: Adenoma prevalence and cancer risk in familial non-pyloposis colorectal cancer. GUT 2002;50:228-234
5. Järvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomäki P, De La Chapelle A, Mecklin J-P: Controlled 15-Year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterol 2000;118:829-834
6. Kronborg O: Colonic screening and surveillance. In: Premalignant conditions of the GI tract: Possibilities for prevention, (ed. Axon A). Best Practice Res Clin Gastroenterol 2001;15:301-316
7. St. John DJ, McDermott FT, Hopper JL, Debney EA, Johnson WR, Hughes ESR: Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med 1993;118:785-790
8. Fuchs CS, Giovanucci EL, Colditz GA: A prospective study of family history and the risk of colorectal cancer. In. W Schmniegel & J Schölmerich (eds.) Colorectal Cancer. Falk Symposium 109, pp 144-54. Dordrecht: Klüwer, 1998
9. Winawer SJ, St. John DJ, Bond JH, Rozen P, Burt RW, Waye JD, Kronborg O, O'Brien MJ, Bishop DT, Kurtz RC, Shike M, Swaroop SV, Levin B, Fruhmorgen P, Lynch HT: Prevention of colorectal cancer: guidelines based on new data. Bulletin of the WHO 1995;73:7-10
10. Winawer SJ, Zauber AG, Gerdes H, O'Brien MJ, Gottlieb LS, Sternberg SS, Bond JH, Waye JD, Schapiro M, Panish JF, Kurtz RC, Shike M, Ackroyd FW, Stewart ET, Skolnick M, Bishop DT, and the National Polyp Study Workgroup: Risk of colorectal cancer in the families of patients with adenomatous polyps. N Engl J Med 1996;334:82-87
11. Kjeldsen BJ: Evaluation of long-term follow-up in patients having had surgery for colorectal cancer with curative intent. PhD thesis Faculty of Health Science, Odense University Denmark, 1998
12. Jeffery GM, Hickey BE, Hider P: Follow-up strategies for patients treated for non-metastatic colorectal cancer. Update Software Ltd, The Cochrane Library 2002, Issue 1
13. Shitoh K, Konishi F Miyakura Y, Togashi K, Okamoto T, Nagai H: Mikrosatellite instability as a marker in predicting metachronous multiple colorectal carcinomas after surgery. Dis Colon Rectum 2002;45:329-333
14. Renehan AG, Egger M, Saunders MP, O'Dwyer ST: The impact on survival of intensive follow-up after curative resection for colorectal cancer: a meta-analysis of randomised trials. BMJ 2002;324:813
15. Eide TJ: Natural history of adenomas. World J Surgery 1991;15:3-6
16. Citarda F, Tomaselli G, Capocaccia R, Barcherini S, Crespi M, The Italian Multicentre Study Group: Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. GUT 2001;48:812-815
17. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, Waye JD, Schapiro M, Bond JH, Panish JF, Ackroyd F, Shike M, Kurtz RC, Hornsby-Lewis L, Gerdes H, Stewart ET and the National Polyp Study Workgroup: Prevention of colorectal cancer by colonoscopic polypectomy. New Engl J Med 1993;329:1977-1981
18. Nusko G, Mansmann U, Kirschner Th, Hahn EG: Risk related surveillance following colorectal polypectomy. Gut 2002;51:424-428
19. Kronborg O, Fenger C: Randomised study of advantages and drawbacks of long-term colorectal adenoma surveillance. Abstract for Tripartite Colorectal Meeting Melbourne, 2002
20. Wilson LS, Lightwood J: Model of estimated rates of colorectal cancer from polyp growth by year of surveillance. J Med Screen 2001;8:187-196
21. Jørgensen OD, Kronborg O, Fenger C: The Funen adenoma follow-up study. Incidence and death of colorectal carcinoma in an adenoma surveillance program. Scand J Gastroenterol 1993;28:869-974
22. Provenzale D, Kawdley KV, Arora S, Wrang JB: Prophylactic colectomy or surveillance for chronic ulcerative colitis? A decision analysis. Gastroenterol 1995;109:1188-1196
23. Eaden J, Abrams K, Ekbom A, Jackson E, Mayberry J: Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther 2000;14:145-153
24. Steele RJC, Parker R, Patnick J, Warner J, Fraser C, Mowat NAG, Wilson J, Alexander FE, Paterson JG, for the United Kingdom Colorectal Screening Pilot Group: A demonstration pilot trial for colorectal cancer screening in the United Kingdom: a new concept in the introduction of healthcare strategies. J Med Screen 2001;8:197-203
25. Kronborg O: Screening for colorectal cancer in the average-risk population. Seminars in Colon Rect Surg 2002;13:16-30
26. Jørgensen OD, Kronborg O, Fenger C: A randomised study for colorectal cancer with faecal occult blood test. Results after 13 years and 7 biennial screening rounds. GUT 2002;50:29-32
27. Scholefield JH, Moss S, Mangham CM, Hardcastle: Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. GUT 2002;50:840-844
28. Nakama H, Zhang B, Zhang X: Evaluation of the optimum cut-off point in immunochemical occult blood testing in screening for colorectal cancer. Eur J Cancer 2001;37:398-401
29. Gyrd-Hansen D: The relative economics of screening for colorectal cancer, breast cancer and cervical cancer. Institute of Public Health, University of Southern Denmark, Odense University. Oncol/Hematol 1999;32:133-144
30. Atkin WS, Edwards, R, Wardle J, Northover JMA, Sutton S, Hart AR, Williams CB, Cusick J: Design of a multicentre randomised trial to evaluate flexible sigmoidoscopy in colorectal cancer screening. J Med Screen 2001;8:137-144
31. Moss SM, Hardcastle JD, Coleman DA, Robinson MHE, Rodriques VC: Interval cancers in a randomised controlled trial of screening for colorectal cancer using a faecal occult blood test. Int J Epidemiol 1999;28:386-390
32. McCallion K, Mitchell RMS, Wilson RH, Kee F, Watson RGP, Collins JSA, Gardiner KR: Flexible sigmoidoscopy and the changing distribution of colorectal cancer: implications for screening. Gut 2001;48:522-525
33. Liebermann DA, Weiss D, for The Veterans Affairs Cooperative Study Group: One-Time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 2001;345:555-560
34. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G, for Veteran affairs kooperative group 380: Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med 2000;343:162-168
35. Rex DK, Lehman GA, Hawes RH, Ulbright TM, Smith JJ: Screening colonoscopy in asymptomatic average-risk persons with negative fecal occult blood tests. Gastroenterol 1991;100:64-67
36. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, Woolf SH, Glick SN, Ganiats TG, Bond JH, Rosen L, Zapka JG, Olsen SJ, Giardiello FM, Sisk JE, van Antwerp R, Brown-Davis C, Marciniak DA, Mayer RJ: Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterol 1997;112:594-642
37. Fletcher JG, Luboldt W: CT colonography and MR colonography: current status, research directions and comparison. Eur Radiol 2000;10:786-801
38. Kronborg O, Ugstad M, Fuglerud P, Johne B, Hardcastle J, Scholefield JH, Vellacott K, Moshakis V, Reynolds JR: Faecal calprotectin levels in a high-risk population for colorectal neoplasia. Gut 2000;46:795-800
39. Davies RJ, Freeman A, Morris LS, Bingham S, Dilworth S, Scott I, Laskey RA, Miller R, Coleman N: Analysis of minichromosome maintenance proteins as a novel method for detection of colorectal cancer in stool. Lancet 2002;359:1917-1919
40. Traverso G, Shuber A, Levin B, Johnson C, Olsson L, Schoetz J, Hamilton SR, Boynton K, Kinzler KW, Vogelstein B: Detection of APCmutations in fecal DNA from patients with colorectal tumors. N Engl J Med 2002;346:311-320
41. Recommendations on cancer screening in the European Union: Advisory Committee on Cancer Prevention. Eur J Cancer 2000;36:1473-1478